All Publications

  1. Braun HJ, Ascher NL. The Impact of Renal Insufficiency Following Liver Transplantation. Transplantation. 2018 Mar 20. View in PubMed
  2. Braun HJ, Ascher NL. Living Donor Liver Transplantation for Alcoholic Liver Disease. Alcohol Alcohol. 2018 Jan 23. View in PubMed
  3. Delmonico FL, Gunderson S, Iyer KR, Danovitch GM, Pruett TL, Reyes JD, Ascher NL. Deceased Donor Organ Transplantation Performed in the United States for Non- Citizens and Non-Residents. Transplantation. 2018 Jan 11. View in PubMed
  4. Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP. A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference. Transplant Direct. 2017 Dec; 3(12):e225. View in PubMed
  5. Lebares CC, Guvva EV, Ascher NL, O'Sullivan PS, Harris HW, Epel ES. Burnout and Stress Among US Surgery Residents: Psychological Distress and Resilience. J Am Coll Surg. 2018 Jan; 226(1):80-90. View in PubMed
  6. Delmonico FL, Ascher NL. Opposition to irresponsible global kidney exchange. Am J Transplant. 2017 Oct; 17(10):2745-2746. View in PubMed
  7. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534. View in PubMed
  8. Pruett TL, Vathsala A, Berney T, Lerut J, Odorico JS, Johnson M, Egawa H, Gonzalez-Martinez F, Haberal M, Ascher NL, Chandraker AK. Criminal Organ Retrieval: Unconscionable. Am J Transplant. 2017 Feb; 17(2):577. View in PubMed
  9. Braun HJ, Ascher NL, Roll GR, Roberts JP. Biliary complications following living donor hepatectomy. Transplant Rev (Orlando). 2016 10; 30(4):247-52. View in PubMed
  10. Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation. Transplantation. 2016 06; 100(6):1244-50. View in PubMed
  11. Braun HJ, Dusch MN, Park SH, O'Sullivan PS, Harari A, Harleman E, Ascher NL. Medical Students' Perceptions of Surgeons: Implications for Teaching and Recruitment. J Surg Educ. 2015 Nov-Dec; 72(6):1195-9. View in PubMed
  12. Ascher NL. Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society. Transplantation. 2015 Jun; 99(6):1106. View in PubMed
  13. Braun HJ, O'Sullivan PS, Dusch MN, Antrum S, Ascher NL. Improving interprofessional collaboration: evaluation of implicit attitudes in the surgeon-nurse relationship. Int J Surg. 2015 Jan; 13:175-9. View in PubMed
  14. Dusch MN, Braun HJ, O'Sullivan PS, Ascher NL. Perceptions of surgeons: what characteristics do women surgeons prefer in a colleague? Am J Surg. 2014 Oct; 208(4):601-4. View in PubMed
  15. Dusch MN, O'Sullivan PS, Ascher NL. Patient perceptions of female surgeons: how surgeon demeanor and type of surgery affect patient preference. J Surg Res. 2014 Mar; 187(1):59-64. View in PubMed
  16. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Ex vivo split-liver transplantation: the true right/left split. HPB (Oxford). 2014 Mar; 16(3):267-74. View in PubMed
  17. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013 May; 19(5):472-81. View in PubMed
  18. Trompeta JA, Cooper BA, Ascher NL, Kools SM, Kennedy CM, Chen JL. Asian American adolescents' willingness to donate organs and engage in family discussion about organ donation and transplantation. Prog Transplant. 2012 Mar; 22(1):33-40, 70. View in PubMed
  19. Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl. 2012 Feb; 18(2):160-5. View in PubMed
  20. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011 Sep; 146(9):1052-9. View in PubMed
  21. Melcher ML, Freise CE, Ascher NL, Roberts JP. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant. Clin Transplant. 2010 Nov-Dec; 24(6):E230-5. View in PubMed
  22. Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers. Clin Transplant. 2010 Sep-Oct; 24(5):E137-44. View in PubMed
  23. Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg. 2011 Jan; 15(1):209-14. View in PubMed
  24. Trompeta JA, Chen JL, Cooper BA, Ascher NL, Kools SM. Development of the Organ Donation and Transplantation Knowledge Survey for use in Asian American adolescents. Transplant Proc. 2010 Jun; 42(5):1427-31. View in PubMed
  25. Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010 May; 16(5):649-57. View in PubMed
  26. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27. View in PubMed
  27. Cloyd J, Holtzman D, O'Sullivan P, Sammann A, Tendick F, Ascher N. Operating room assist: surgical mentorship and operating room experience for preclerkship medical students. J Surg Educ. 2008 Jul-Aug; 65(4):275-82. View in PubMed
  28. Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP, Ascher NL, Posselt AM. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008 Mar-Apr; 4(2):159-64; discussion 164-5. View in PubMed
  29. Hirose R, Yao F, Stock P, Roberts J, Ascher N. Liver transplantation at UCSF--a 20-year experience. Clin Transpl. 2008; 119-25. View in PubMed
  30. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008 Feb; 8(2):355-65. View in PubMed
  31. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007 Nov; 7(11):2587-96. View in PubMed
  32. Sammann A, Tendick F, Ward D, Zaid H, O'Sullivan P, Ascher N. A surgical skills elective to expose preclinical medical students to surgery. J Surg Res. 2007 Oct; 142(2):287-94. View in PubMed
  33. Derish PA, Maa J, Ascher NL, Harris HW. Enhancing the mission of academic surgery by promoting scientific writing skills. J Surg Res. 2007 Jun 15; 140(2):177-83. View in PubMed
  34. Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP. Central venous pressure monitoring during living right donor hepatectomy. Liver Transpl. 2007 Feb; 13(2):266-71. View in PubMed
  35. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Paul SM, Dodd MJ, Painter PL. A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant. 2006 Aug; 6(8):1896-905. View in PubMed
  36. Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O'connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006 Feb; 6(2):281-91. View in PubMed
  37. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005 Dec; 11(12):1505-14. View in PubMed
  38. Derish P, Ascher NL. The Department of Surgery, University of California, San Francisco. Arch Surg. 2005 Dec; 140(12):1143-8. View in PubMed
  39. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant. 2005 Aug; 19(4):501-6. View in PubMed
  40. Kusano T, Randall HB, Roberts JP, Ascher NL. The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology. 2005 May-Jun; 52(63):695-9. View in PubMed
  41. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005 Apr; 5(4 Pt 1):795-804. View in PubMed
  42. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Dodd MJ, Painter PL. Objective measures of health-related quality of life over 24 months post-liver transplantation. Clin Transplant. 2005 Feb; 19(1):1-9. View in PubMed
  43. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl. 2004 May; 10(5):621-30. View in PubMed
  44. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. View in PubMed
  45. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split-liver transplantation in the United States: outcomes of a national survey. Ann Surg. 2004 Feb; 239(2):172-81. View in PubMed
  46. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004 Jan; 39(1):230-8. View in PubMed
  47. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl. 2003 Oct; 9(10):1102-7. View in PubMed
  48. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant. 2003 Oct; 3(10):1259-63. View in PubMed
  49. Painter PL, Hector L, Ray K, Lynes L, Paul SM, Dodd M, Tomlanovich SL, Ascher NL. Effects of exercise training on coronary heart disease risk factors in renal transplant recipients. Am J Kidney Dis. 2003 Aug; 42(2):362-9. View in PubMed
  50. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27; 76(2):370-5. View in PubMed
  51. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl. 2003 Jul; 9(7):684-92. View in PubMed
  52. Ascher NL. Analysis of research projects in living donor organ transplantation. Transplant Proc. 2003 May; 35(3):907-8. View in PubMed
  53. Ascher NL. What's new in general surgery: transplantation. J Am Coll Surg. 2003 May; 196(5):778-83. View in PubMed
  54. Niemann CU, Roberts JP, Ascher NL, Yost CS. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl. 2002 Dec; 8(12):1126-32. View in PubMed
  55. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002 Oct; 8(10):873-83. View in PubMed
  56. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002 Sep; 8(9):765-74. View in PubMed
  57. Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatr Transplant. 2002 Aug; 6(4):301-7. View in PubMed
  58. Painter PL, Hector L, Ray K, Lynes L, Dibble S, Paul SM, Tomlanovich SL, Ascher NL. A randomized trial of exercise training after renal transplantation. Transplantation. 2002 Jul 15; 74(1):42-8. View in PubMed
  59. Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P. Donor health assessment after living-donor liver transplantation. Ann Surg. 2002 Jul; 236(1):120-6. View in PubMed
  60. Renz JF, Ascher NL. Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence. World J Surg. 2002 Feb; 26(2):247-56. View in PubMed
  61. Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC. Posttransplantation growth in pediatric liver recipients. Liver Transpl. 2001 Dec; 7(12):1040-55. View in PubMed
  62. Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation. 2001 Sep 15; 72(5):791-7. View in PubMed
  63. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001 Jun; 33(6):1394-403. View in PubMed
  64. Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant recipients. Liver Transpl. 2001 Mar; 7(3):213-9. View in PubMed
  65. Koh BY, Rosenthal P, Medeiros LJ, Osorio RW, Roberts JP, Ascher NL, Gelb AB. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation. Arch Pathol Lab Med. 2001 Mar; 125(3):337-43. View in PubMed
  66. Ascher NL. Immunosuppressant substitutes in liver transplantation. Lancet. 2001 Feb 24; 357(9256):571-2. View in PubMed
  67. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant. 2000 Dec; 14(6):550-4. View in PubMed
  68. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40. View in PubMed
  69. Reichert PR, Renz JF, D'Albuquerque LA, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg. 2000 Nov; 232(5):658-64. View in PubMed
  70. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg. 2000 Sep; 135(9):1016-9; discussion 1019-20. View in PubMed
  71. Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Transplantation. 2000 May 15; 69(9):1813-7. View in PubMed
  72. O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation. 2000 Apr 15; 69(7):1440-6. View in PubMed
  73. O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant. 2000 Apr; 14(2):167-73. View in PubMed
  74. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000 Jan 27; 69(2):307-11. View in PubMed
  75. Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc. 1999 Aug; 31(5):1955-6. View in PubMed
  76. Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, Roberts JP. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. Transplantation. 1999 Mar 15; 67(5):707-12. View in PubMed
  77. Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver Transpl Surg. 1999 Mar; 5(2):136-43. View in PubMed
  78. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation. 1999 Feb 27; 67(4):510-3. View in PubMed
  79. Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation. Clin Transplant. 1998 Dec; 12(6):508-10. View in PubMed
  80. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg. 1998 Nov; 4(6):461-8. View in PubMed
  81. Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawarasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc. 1998 Nov; 30(7):3321-3. View in PubMed
  82. Reichert PR, Renz JF, Rosenthal P, Bacchetti P, Lim RC, Roberts JP, Ascher NL, Emond JC. Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg. 1998 Sep; 4(5):343-9. View in PubMed
  83. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 1998 Aug; 28(2):555-61. View in PubMed
  84. Lightdale JR, Mudge CL, Ascher NL, Rosenthal P. The role of pediatricians in the care of children with liver transplants. Arch Pediatr Adolesc Med. 1998 Aug; 152(8):797-802. View in PubMed
  85. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998 Apr 27; 65(8):1053-60. View in PubMed
  86. Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine. Transplantation. 1998 Apr 15; 65(7):995-7. View in PubMed
  87. Kang SM, Lin Z, Ascher NL, Stock PG. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant Proc. 1998 Mar; 30(2):538. View in PubMed
  88. Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg. 1998 Mar; 4(2):170-6. View in PubMed
  89. Kaufman DB, Ascher NL. Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons. Transplantation. 1998 Jan 27; 65(2):269-72. View in PubMed
  90. Ascher NL. Interleukin-2 receptor antibody therapy. Liver Transpl Surg. 1997 Nov; 3(6):643-4. View in PubMed
  91. Brown RS, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Roberts JP. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg. 1997 Oct; 132(10):1098-103. View in PubMed
  92. Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC. Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization. Arch Surg. 1997 Sep; 132(9):950-5; discussion 955-6. View in PubMed
  93. Rosenthal P, Roberts JP, Ascher NL, Emond JC. Auxiliary liver transplant in fulminant failure. Pediatrics. 1997 Aug; 100(2):E10. View in PubMed
  94. Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC. Increased immune responses to regenerating partial liver grafts in the rat. J Surg Res. 1997 Jun; 70(1):34-40. View in PubMed
  95. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 1997 May; 25(5):1266-70. View in PubMed
  96. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zetterman RK. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation. 1997 Apr 27; 63(8):1074-9. View in PubMed
  97. Ascher NL. The role of the host immune state in recurrent hepatitis C. Liver Transpl Surg. 1997 Mar; 3(2):179-80. View in PubMed
  98. Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY. Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. Transplantation. 1997 Feb 27; 63(4):609-12. View in PubMed
  99. Orloff SL, Hirose R, Lin Z, Narumi S, Stock PG, Ascher NL. Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras. Transplant Proc. 1997 Feb-Mar; 29(1-2):1198-200. View in PubMed
  100. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JY, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 1996 Dec; 111(6):1569-75. View in PubMed
  101. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec; 24(6):1327-33. View in PubMed
  102. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov; 24(5):1041-6. View in PubMed
  103. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg. 1996 Oct; 224(4):544-52; discussion 552-4. View in PubMed
  104. Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation. 1996 Sep 27; 62(6):742-7. View in PubMed
  105. Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL. Liver transplantation improves survival of rats bearing hepatoma-3924A. J Surg Res. 1996 Sep; 65(1):59-62. View in PubMed
  106. Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL. SCID mouse as a model for transplantation studies. J Surg Res. 1996 Sep; 65(1):34-41. View in PubMed
  107. Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC. Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg. 1996 Aug; 131(8):887-92; discussion 892-3. View in PubMed
  108. Freise CE, Liu T, Ascher NL, Roberts JP. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma. J Surg Res. 1996 Aug; 64(2):198-202. View in PubMed
  109. Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL. Living related donor liver transplantation: the UCSF experience. Transplant Proc. 1996 Aug; 28(4):2375-7. View in PubMed
  110. Emond JC, Stock P, Roberts JP, Ascher NL. Strategies for tolerance induction: potential applications in living donor liver transplantation. Transplant Proc. 1996 Aug; 28(4):2371-4. View in PubMed
  111. Omura T, Ascher NL, Emond JC. Fifty-percent partial liver transplantation in the rat. Transplantation. 1996 Jul 27; 62(2):292-3. View in PubMed
  112. Ascher NL. Expanding the immunosuppressive repertoire. Liver Transpl Surg. 1996 Jul; 2(4):304-5. View in PubMed
  113. Ascher NL. Advances in biliary reconstruction after liver transplantation. Liver Transpl Surg. 1996 May; 2(3):238-9. View in PubMed
  114. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar; 2(2):132-8. View in PubMed
  115. Gish RG, Ascher NL. Transmission of hepatitis B virus through allotransplantation. Liver Transpl Surg. 1996 Mar; 2(2):161-4. View in PubMed
  116. Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996 Feb 27; 61(4):666-9. View in PubMed
  117. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP. The use of the T tube after orthotopic liver transplantation. Transplantation. 1996 Jan 27; 61(2):258-61. View in PubMed
  118. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 1996 Jan; 110(1):265-70. View in PubMed
  119. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol. 1995 Dec; 104(6):673-9. View in PubMed
  120. Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP. Increased efficacy of CSA following rearterialization in the rat OLTX model. J Surg Res. 1995 Oct; 59(4):493-6. View in PubMed
  121. Detre KM, Lombardero M, Belle S, Beringer K, Breen T, Daily OP, Ascher NL. Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg. 1995 Sep; 1(5):311-9. View in PubMed
  122. Ascher NL. Issues in xenotransplantation. Liver Transpl Surg. 1995 Sep; 1(5):320-1. View in PubMed
  123. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology. 1995 Aug; 22(2):451-7. View in PubMed
  124. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg. 1995 Aug; 130(8):824-30; discussion 830-1. View in PubMed
  125. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg. 1995 Jul; 1(4):242-8. View in PubMed
  126. Ascher NL. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Liver Transpl Surg. 1995 Jul; 1(4):256-7. View in PubMed
  127. Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals. Biopharm Drug Dispos. 1995 May; 16(4):303-12. View in PubMed
  128. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr; 108(4):1143-51. View in PubMed
  129. McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation. 1995 Feb 27; 59(4):530-6. View in PubMed
  130. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR. Impact of transjugular intrahepatic portosystemic shunts on liver transplantation: a controlled analysis. NIDDK Liver Transplantation Database. Transplant Proc. 1995 Feb; 27(1):1248-9. View in PubMed
  131. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995 Jan 27; 59(2):230-4. View in PubMed
  132. Ascher NL. Immunosuppressive therapy in liver transplantation: principles and practice. Prog Liver Dis. 1995; 13:381-95. View in PubMed
  133. Ascher NL. Microchimerism in organ transplantation. Liver Transpl Surg. 1995 Jan; 1(1):43-6. View in PubMed
  134. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology. 1994 Jul; 20(1 Pt 2):24S-27S. View in PubMed
  135. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1994 Jul; 20(1 Pt 1):105-10. View in PubMed
  136. Osorio RW, Ascher NL, Melzer JS, Stock PG. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody. Transplant Proc. 1994 Apr; 26(2):749. View in PubMed
  137. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr; 106(4):994-9. View in PubMed
  138. Osorio RW, Ascher NL, Melzer JS, Stock PG. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice. Transplant Proc. 1994 Apr; 26(2):752. View in PubMed
  139. Osorio RW, Ascher NL, Stock PG. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Transplantation. 1994 Mar 27; 57(6):783-8. View in PubMed
  140. Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. Transplantation. 1994 Mar 27; 57(6):928-32. View in PubMed
  141. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994 Jan 15; 343(8890):142-6. View in PubMed
  142. Ascher NL. Liver transplantation and the Najarian footprint. Am J Surg. 1993 Nov; 166(5):509-11. View in PubMed
  143. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes. 1993 Oct; 42(10):1520-7. View in PubMed
  144. Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation. 1993 Oct; 56(4):1021-3. View in PubMed
  145. Evans RW, Manninen DL, Dong FB, Ascher NL, Frist WH, Hansen JA, Kirklin JK, Perkins JD, Pirsch JD, Sanfilippo FP. Immunosuppressive therapy as a determinant of transplantation outcomes. Transplantation. 1993 Jun; 55(6):1297-305. View in PubMed
  146. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg. 1993 Jun; 128(6):677-82. View in PubMed
  147. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993 May; 187(2):413-20. View in PubMed
  148. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation. 1993 May; 55(5):1159-66. View in PubMed
  149. Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP. Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation. 1993 May; 55(5):1074-7. View in PubMed
  150. Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, Krams SM. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation. 1993 Apr; 55(4):909-18. View in PubMed
  151. Ascher NL. Immunosuppression and rejection in liver transplantation. Transplant Proc. 1993 Apr; 25(2):1744-5. View in PubMed
  152. Freise CE, Hebert M, Osorio RW, Nikolai B, Lake JR, Kauffman RS, Ascher NL, Roberts JP. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Transplant Proc. 1993 Apr; 25(2):1758-9. View in PubMed
  153. Orians CE, Evans RW, Ascher NL. Estimates of organ-specific donor availability for the United States. Transplant Proc. 1993 Feb; 25(1 Pt 2):1541-2. View in PubMed
  154. Martinez OM, Krams SM, Villanueva JC, Ferrell L, Lake J, Roberts JP, Ascher NL. Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):126-7. View in PubMed
  155. Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG. Isolation of functional MHC class I-deficient islet cells. Transplant Proc. 1993 Feb; 25(1 Pt 2):968-9. View in PubMed
  156. Osorio RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR. Orthotopic liver transplantation for end-stage alcoholic liver disease. Transplant Proc. 1993 Feb; 25(1 Pt 2):1133-4. View in PubMed
  157. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3. View in PubMed
  158. Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, Poplawski S, Sollinger H, Roberts J. RS-61443 for treatment-resistant human liver rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):697. View in PubMed
  159. Stock PG, Ascher NL, Osorio RW, Tomlanovich S, Lake JR, Nikolai B, Freise C, Roberts JP. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. Transplant Proc. 1993 Feb; 25(1 Pt 1):675-6. View in PubMed
  160. Krams SM, Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL. T-cell receptor-V alpha gene use in sequential liver allograft biopsies. Transplant Proc. 1993 Feb; 25(1 Pt 1):84-5. View in PubMed
  161. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7. View in PubMed
  162. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88. View in PubMed
  163. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation at the University of California, San Francisco. Clin Transpl. 1993; 175-7. View in PubMed
  164. Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology. 1992 Aug; 77(2):375-8. View in PubMed
  165. LaBerge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher NL. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg. 1992 Aug; 16(2):258-67. View in PubMed
  166. Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation. 1992 Jul; 54(1):179-80. View in PubMed
  167. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992 Jul; 16(1):1-7. View in PubMed
  168. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul; 103(1):317-22. View in PubMed
  169. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 1992 Apr 18; 339(8799):952-5. View in PubMed
  170. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med. 1992 Feb 15; 116(4):304-9. View in PubMed
  171. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL. Intragraft cytokine profile during human liver allograft rejection. Transplantation. 1992 Feb; 53(2):449-56. View in PubMed
  172. Lake JR, Roberts JP, Ascher NL. Maintenance immunosuppression after liver transplantation. Semin Liver Dis. 1992 Feb; 12(1):73-9. View in PubMed
  173. Evans RW, Orians CE, Ascher NL. The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA. 1992 Jan 08; 267(2):239-46. View in PubMed
  174. Prager MC, Johnson KL, Ascher NL, Roberts JP. Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg. 1992 Jan; 74(1):162-4. View in PubMed
  175. Hebert MF, Ascher NL, Lake JR, Roberts JP. Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Transplant Proc. 1991 Dec; 23(6):3109-10. View in PubMed
  176. Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc. 1991 Dec; 23(6):3173-4. View in PubMed
  177. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1991 Nov; 2(4):549-56. View in PubMed
  178. Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation. 1991 Oct; 52(4):704-9. View in PubMed
  179. Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL. Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model. Transplantation. 1991 Aug; 52(2):318-25. View in PubMed
  180. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology. 1991 Aug; 14(2):274-81. View in PubMed
  181. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 1991 Jul 15; 115(2):111-2. View in PubMed
  182. Roberts JP, Ring E, Lake JR, Sterneck M, Ascher NL. Intrahepatic portocaval shunt for variceal hemorrhage prior to liver transplantation. Transplantation. 1991 Jul; 52(1):160-2. View in PubMed
  183. Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr; 95(4):499-502. View in PubMed
  184. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15; 114(4):282-4. View in PubMed
  185. Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP. Characterization of a cyclosporine-containing liposome. Transplant Proc. 1991 Feb; 23(1 Pt 1):473-4. View in PubMed
  186. Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1498-500. View in PubMed
  187. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1504-5. View in PubMed
  188. Burke EC, Martinez OM, Freise CE, McVicar J, Roberts JP, Ascher NL. MHC expression on human hepatocytes before and after isolation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1428-9. View in PubMed
  189. Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE. The alloimmune response against pancreatic islets is generated by both direct and indirect pathways. Transplant Proc. 1991 Feb; 23(1 Pt 1):819-20. View in PubMed
  190. Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation. Gastroenterology. 1991 Jan; 100(1):263-7. View in PubMed
  191. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol. 1990 Nov; 1(1):17-22. View in PubMed
  192. Roberts JP, Hughes L, Goldstone J, Ascher NL. Examination of vascular anastomoses during liver transplantation by intraoperative Doppler duplex scanning. Clin Transplant. 1990 Aug; 4(4):206-9. View in PubMed
  193. Pinson CW, Daya MR, Benner KG, Norton RL, Deveney KE, Ascher NL, Roberts JP, Lake JR, Kurkchubasche AG, Ragsdale JW. Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg. 1990 May; 159(5):493-9. View in PubMed
  194. Ostroff JW, Roberts JP, Gordon RL, Ring EJ, Ascher NL. The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters. Transplantation. 1990 May; 49(5):922-4. View in PubMed
  195. Stock PG, Ascher NL, Chen S, Bumgardner G, Field MJ, Sutherland DE. The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes. Transplant Proc. 1990 Apr; 22(2):841-3. View in PubMed
  196. Prager MC, Gregory GA, Ascher NL, Roberts JP. Massive venous air embolism during orthotopic liver transplantation. Anesthesiology. 1990 Jan; 72(1):198-200. View in PubMed
  197. Roberts JP, Ascher NL, Fryd DS, Hunter DW, Dunn DL, Payne WD, Sutherland DE, Castaneda-Zuniga W, Najarian JS. Transplant renal artery stenosis. Transplantation. 1989 Oct; 48(4):580-3. View in PubMed
  198. Ascher NL. Selection criteria for liver transplantation donors. Transplant Proc. 1989 Jun; 21(3):3482-3. View in PubMed
  199. Stock PG, Ascher NL, Chen S, Bumgardner GL, Field MJ, Sutherland DE. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity. J Surg Res. 1989 Apr; 46(4):317-21. View in PubMed
  200. Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Thompson WM, Najarian JS, Castaneda-Zuniga WR, Day DL. Biliary complications after liver transplantation in children. Radiology. 1989 Mar; 170(3 Pt 2):1095-9. View in PubMed
  201. Meloche M, Bumgardner G, Stock P, Chen S, Ascher NL, Sutherland DE. Comparative in vitro immunogenicity of cultured murine islets and hepatocytes. Transplant Proc. 1989 Feb; 21(1 Pt 3):2682-4. View in PubMed
  202. Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL. Factors influencing early survival after liver transplantation. Am J Surg. 1989 Feb; 157(2):215-9. View in PubMed
  203. Stock PG, Clemmings SM, Han D, Sutherland DE, Ascher NL. Frequency of precursor cytotoxic T lymphocytes correlates with outcome following heart-lung and pancreatic islet transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 1):457-60. View in PubMed
  204. Fischel RJ, Ascher NL, Payne WD, Freese DK, Stock P, Fasola C, Najarian JS. Pediatric liver transplantation across ABO blood group barriers. Transplant Proc. 1989 Feb; 21(1 Pt 2):2221-2. View in PubMed
  205. Stock PG, Payne WD, Ascher NL, Roberts JP, Belani K, Estrin J, Najarian JS. Rapid infusion technique as a safe alternative to veno-venous bypass in orthotopic liver transplant (TX). Transplant Proc. 1989 Feb; 21(1 Pt 2):2322-5. View in PubMed
  206. Stock PG, Ascher NL, Platt JL, Kaufman DB, Chen S, Field MJ, Sutherland DE. Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture. Diabetes. 1989 Jan; 38 Suppl 1:157-60. View in PubMed
  207. Stock PG, Meloche M, Ascher NL, Chen S, Bach FH, Sutherland DE. Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells. Diabetes. 1989 Jan; 38 Suppl 1:161-4. View in PubMed
  208. Roberts JP, Forsmark C, Lake JR, Ascher NL. Liver transplantation today. Annu Rev Med. 1989; 40:287-303. View in PubMed
  209. Chan GL, Erdmann GR, Gruber SA, Stock P, Chen S, Ascher NL, Canafax DM. Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. Eur J Clin Pharmacol. 1989; 36(3):265-71. View in PubMed
  210. Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet. 1988 Dec; 167(6):474-84. View in PubMed
  211. Burke GW, Ascher NL, Hunter D, Najarian JS. Orthotopic liver transplantation: nonoperative management of early, acute portal vein thrombosis. Surgery. 1988 Nov; 104(5):924-8. View in PubMed
  212. Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS. Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation. 1988 Nov; 46(5):703-9. View in PubMed
  213. Bumgardner GL, Stock PG, Payne WD, Najarian JS, Ascher NL. [Comparison of the results of liver transplantation in children and adults]. Chirurg. 1988 Aug; 59(8):526-35. View in PubMed
  214. Stock PG, Ascher NL, Kaufman DB, Chen S, Meloche M, Field MJ, Sutherland DE. In vitro generated allospecific cytolytic T lymphocytes injure pancreatic islets. J Surg Res. 1988 Jul; 45(1):74-81. View in PubMed
  215. Kaufman DB, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS. A single-center experience of renal transplantation in thirteen Jehovah's Witnesses. Transplantation. 1988 Jun; 45(6):1045-9. View in PubMed
  216. Najarian JS, Migliori RJ, Simmons RL, Ascher NL, Payne WD, Dunn D, Sutherland DE, Fryd DS. Effects of HLA matching in cadaver renal transplants. Transplant Proc. 1988 Jun; 20(3 Suppl 3):249-56. View in PubMed
  217. Dalen K, Day DL, Ascher NL, Hunter DW, Thompson WM, Castaneda-Zuniga WR, Letourneau JG. Imaging of vascular complications after hepatic transplantation. AJR Am J Roentgenol. 1988 Jun; 150(6):1285-90. View in PubMed
  218. Letourneau JG, Day DL, Hunter DW, Ascher NL, Najarian JS, Thompson WM, Castaneda-Zuniga WR. Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis. Radiology. 1988 May; 167(2):349-51. View in PubMed
  219. Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Transplantation. 1988 Feb; 45(2):380-5. View in PubMed
  220. Stock PG, Sutherland DE, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS. ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation. Transplant Proc. 1987 Dec; 19(6):4522-4. View in PubMed
  221. Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation. 1987 Dec; 44(6):775-8. View in PubMed
  222. Letourneau JG, Day DL, Ascher NL, Snover DC, Steely JW, Crass JR, Najarian JS, Feinberg SB. Abdominal sonography after hepatic transplantation: results in 36 patients. AJR Am J Roentgenol. 1987 Aug; 149(2):299-303. View in PubMed
  223. Stock PG, Ascher NL, Najarian JS. Pediatric liver transplantation using combination immunosuppressive therapy. Transplant Proc. 1987 Aug; 19(4):3303-8. View in PubMed
  224. Letourneau JG, Day DL, Maile CW, Crass JR, Ascher NL, Frick MP. Liver allograft transplantation: postoperative CT findings. AJR Am J Roentgenol. 1987 Jun; 148(6):1099-103. View in PubMed
  225. Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL. Hepatitis-associated aplastic anemia after liver transplantation. Transplantation. 1987 Apr; 43(4):595-7. View in PubMed
  226. Letourneau JG, Day DL, Frick MP, Steely JW, Maile CW, Ascher NL, Feinberg SB. Ultrasound and computed tomographic evaluation in hepatic transplantation. Radiol Clin North Am. 1987 Mar; 25(2):323-31. View in PubMed
  227. Snover DC, Freese DK, Bloomer JR, Sharp HL, Ascher NL. An analysis of histological prognostic features of liver allograft rejection based on 270 serial biopsies. Transplant Proc. 1987 Feb; 19(1 Pt 3):2457-8. View in PubMed
  228. Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS. Cox regression analysis of outcome risk factors in 519 renal allograft recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):1947-8. View in PubMed
  229. Ascher NL, Evans RW. Designation of liver transplant centers in the United States. Transplant Proc. 1987 Feb; 19(1 Pt 3):2405. View in PubMed
  230. Stock P, Sutherland DE, Fryd DS, Ascher NL, Payne WD, Simmons RL, Najarian JS. Detrimental effect of ABO mismatching in renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):711-2. View in PubMed
  231. Becker WK, Stock P, Fath JJ, Konstantinides FN, Ascher NL, Cerra FB. Plasma amino acid clearance predicts hepatic recovery after normothermic anoxia and cold preservation. Transplant Proc. 1987 Feb; 19(1 Pt 2):1331. View in PubMed
  232. Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL. Prognostic perioperative factors predicting the outcome of liver transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2427-8. View in PubMed
  233. St Cyr JA, Elick B, Freese D, Sharp H, Payne W, Bloomer J, Stock P, Snover D, Najarian JS, Ascher NL. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2451-3. View in PubMed
  234. So SK, Platt JL, Ascher NL, Snover DC. Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation. 1987 Jan; 43(1):79-85. View in PubMed
  235. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol. 1987 Jan; 11(1):1-10. View in PubMed
  236. Migliori RJ, Simmons RL, Payne WD, Ascher NL, Sutherland DE, Najarian JS, Fryd D. Renal transplantation done safely without prior chronic dialysis therapy. Transplantation. 1987 Jan; 43(1):51-5. View in PubMed
  237. Day DL, Letourneau JG, Allan BT, Ascher NL, Lund G. MR evaluation of the portal vein in pediatric liver transplant candidates. AJR Am J Roentgenol. 1986 Nov; 147(5):1027-30. View in PubMed
  238. Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM. The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg. 1986 Sep; 204(3):246-58. View in PubMed
  239. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 1986 Jun; 90(6):2004-7. View in PubMed
  240. Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc. 1986 Apr; 18(2 Suppl 1):192-6. View in PubMed
  241. Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DE, Najarian JS. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc. 1986 Apr; 18(2 Suppl 1):76-81. View in PubMed
  242. Loken MK, Ascher NL, Boudreau RJ, Najarian JS. Scintigraphic evaluation of liver transplant function. J Nucl Med. 1986 Apr; 27(4):451-9. View in PubMed
  243. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation. 1986 Feb; 41(2):177-81. View in PubMed
  244. Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DE, Najarian JS. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc. 1985 Aug; 17(4 Suppl 1):266-75. View in PubMed
  245. Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis. 1985 Jun; 5(6):318-27. View in PubMed
  246. Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg. 1985 Feb; 201(2):142-57. View in PubMed
  247. Sutherland DE, Weiland D, Chavers B, Simmons RL, Ascher NL, Najarian JS. Information and long-term follow-up of a large number of related kidney donors at a single institution. Neth J Med. 1985; 28(6):254-6. View in PubMed
  248. Najarian JS, Weiland D, Chavers B, Simmons RL, Payne WD, Ascher NL, Sutherland DE. Studies on living related kidney donors at a single institution. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985; 21:911-9. View in PubMed
  249. Sutherland DE, Fryd DS, So SK, Bentley FR, Ascher NL, Simmons RL, Najarian JS. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation. 1984 Dec; 38(6):619-24. View in PubMed
  250. Bentley FR, Sutherland DE, Fryd DS, Kaufman D, Ascher NL, Simmons RL, Najarian JS. Similar renal allograft functional survival rates for kidneys from sibling donors matched for zero-versus-one haplotype with the recipient. Transplantation. 1984 Dec; 38(6):674-9. View in PubMed
  251. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology. 1984 Nov-Dec; 4(6):1212-22. View in PubMed
  252. Fath JJ, Ascher NL, Konstantinides FN, Bloomer J, Sharp H, Najarian JS, Cerra FB. Metabolism during hepatic transplantation: indicators of allograft function. Surgery. 1984 Oct; 96(4):664-74. View in PubMed
  253. Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, Ascher NL, Najarian JS. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation. Am J Kidney Dis. 1984 May; 3(6):456-61. View in PubMed
  254. Ascher NL, Najarian JS. Hepatic transplantation and biliary atresia: early experience in eight patients. World J Surg. 1984 Feb; 8(1):57-63. View in PubMed
  255. Ascher NL, Simmons RL, Fryd D, Noreen H, Najarian JS. Effects of HLA-A and B matching on success of cadaver grafts at a single center. Transplantation. 1979 Sep; 28(3):172-8. View in PubMed
  256. Marker SC, Ascher NL, Kalis JM, Simmons RL, Najarian JS, Balfour HH. Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery. 1979 Apr; 85(4):433-40. View in PubMed
  257. Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, Frick MP, Henke C, McCullough J. Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg. 1979 Apr; 114(4):386-92. View in PubMed
  258. Ascher NL, Simmons RL, Noreen H, VanHook J, Howard RJ, Sutherland DE, Najarian JS. 100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility. Ann Surg. 1979 Feb; 189(2):209-16. View in PubMed
  259. Ascher NL, Ahrenholz DH, Simmons RL, Najarian JS. 100 second renal allografts from a single transplantation institution. Transplantation. 1979 Jan; 27(1):30-4. View in PubMed
  260. Mozes MF, Ascher NL, Balfour HH, Simmons RL, Najarian JS. Jaundice after renal allotransplantation. Ann Surg. 1978 Dec; 188(6):783-90. View in PubMed
  261. Ascher NL, Simmons RL, Marker S, Klugman J, Najarian JS. Tuberculous joint disease in transplant patients. Am J Surg. 1978 Jun; 135(6):853-6. View in PubMed
  262. Ascher NL, Simmons RL, Marker S, Najarian JS. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan; 113(1):90-4. View in PubMed
Data provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Nancy L. Ascher, M.D., Ph.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.